RecruitingNot Applicable

A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients

United States60 participantsStarted 2023-11-02

Plain-language summary

To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age equal or greater than 18 years
. Patients who are admitted in the hospital and have received a cancer diagnosis.
. Suffering from solid cancer or hematological malignancy and receiving active treatment for their cancer.
. Voluntary written consent.
. Fluent in English or Spanish.

Exclusion criteria

. Not being able to use a digital tablet
. Being speech impaired or vision impaired
. Patients who are cognitively impaired and unable to read or consent for the study
. Pregnant women

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The Edmonton Symptom Assessment System, (ESAS) questionnaires

Timeframe: through study completion; an average 1 year.

Trial details

NCT IDNCT06127121

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-08-31

Contact for this trial

Carlos Roldan, MD

(713) 563-7402 croldan@mdanderson.org

View on ClinicalTrials.gov More Cancer trials